|
|
||||||||
|
|
|||||||||
|
|
Radiopharmaceutical Chemistry: Special SessionsRadiopharmaceutical Sciences Council Young Investigator Award Symposium |
1 Dept. of Chemistry; 2 Dept. of Radiology, University of Iowa, Iowa City, Iowa
49
Objectives: Mutants of small, well-folded protein and peptide scaffolds were designed with preorganized, histidine-rich binding pockets resulting in local environments in the protein structure suitable for binding Tc(CO)3+ without needing non-natural chelators and spacers.
Methods: Two mutants of ubiquitin (3HIU and 3HPU) were designed to incorporate a 3-histidine insertion with glycine spacers at residue 9 of the protein or three histidine point mutations near the 35-38 turn, respectively. In the "Trp-cage" mutant, two histidine point mutations were made on the N-terminal helix with the third histidine added in a 4-glycine N-terminal tail. [99mTc(CO)3(H2O)3]+ was made by standard procedures, then added to mutant proteins at a final protein concentration of 50 µM. 99mTc-binding was verified by RP-HPLC. To test for protein/metal stability, free L-histidine was added to these 99mTc + mutant reactions to a final concentration of 57 µM. Tc-protein complex stability was examined by RP-HPLC for Tc-99m release.
Results: All three mutants show binding of the [Tc(CO)3]+ species. HPLC analysis showed that the [Tc(CO)3]+ in the 3HIU and 3HTCb complexes is not labile in the presence of excess histidine. However, the 3HPU-Tc-99m complex was not stable to excess histidine.
Conclusions: Preliminary results show that proteins and peptides can be engineered to bind directly to Tc(CO)3+ without the need for non-natural chelators. These experiments demonstrate the possibility of designing proteins and peptides with Tc-coordinating ligands incorporated into the protein structure.
Research Support: NSF, MCB-045119
| ||||||||||||||||||||||||||||||||||||||